Zacks Investment Research on MSN
OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data
Shares of Ovid Therapeutics OVID rallied 39.2% primarily driven by the encouraging top-line data readout from an early-stage ...
The illustration shows the study design, combining population health data, follow-up studies, and genetic insights to reveal ...
Zacks Investment Research on MSN
TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals
Shares of Tvardi Therapeutics TVRD nosedived 83.9% on Monday after the company provided a disappointing update following an ...
Online databases and AI platforms depict women as younger than men across professions, according to a study conducted at UC ...
According to a new Physical Review Letters study, black holes could help solve the dark matter mystery. The shadowy regions ...
Researchers have developed new software for exploring and communicating animal movements in the wild. This suite of ...
TIME has published its third annual list of the World's Best Companies, in partnership with Statista, a leading international provider of market and consumer data and rankings. The result of this ...
Artificial-intelligence agents — touted as AI's next wave — could be vulnerable to malicious code hidden in innocent-looking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results